COVID-19 drug prices reduced by 27% by Glenmark Pharma
New Delhi: The pharma giant Glenmark Pharmaceuticals on Monday said it has reduced the prices of its antiviral drug Favipiravir, under the brand name FabiFlu, for treating the patients with…
Emotion First, Information Second- Key in COVID Communication
New Delhi/Noida: The role of Public Health Communication in times of COVID-19 pandemic is crucial. An empathising, accurate and well-developed health communication can facilitate people to handle uncertainty and fear during…
Timely administration of Clot-Busting Medication saves Senior in Manipal Hospital
New Delhi: Experts says early administration of Clot-busting medication after Stroke is crucial in saving lives and preventing long-term disability. That is exactly what happened in case of Ganesh Nath (name…
COVID-19: FDA Haryana gathers details on medicines to prevent black-marketing
Gurugram: The district drug control department of Food and Drugs Administration (FDA) Haryana is seeking the details from private hospitals in the city regarding the availability of approved Covid-19 medicines…
Esomeprazole tablets launched by Cadila Pharma in India
Cadila Pharmaceuticals (Ahemdabad) has announced the launching of esomeprazole tablets for the treatment of hyperacidity and drug-induced gastritis under the brand name Esiloc. As per the statement of the company,…
DCGI: Itolizumab approved for restricted emergency use in COVID-19
The Drugs Controller General of India has approved Itolizumab, the medicine used to cure psoriasis for “restricted emergency use” againat the treatment of COVID-19 patients with moderate to severe acute…
Premas Biotech SARS-Cov-2 Vaccine Candidate moves for Animal Trials
Gurgaon: Gurgaon-based Premas Biotech, which developed the world’s first triple antigen virus-like particle (VLP) vaccine candidate for SARS CoV-2 virus, announces that it has progressed into animal trials. At the…
IIIT Delhi develops Artificial Intelligence Model for COVID
New Delhi: In a bid to counter the Coronavirus pandemic that has been rampaging around the world, IIIT Delhi has worked on computational AI (Artificial Intelligence) model for drug repositioning…
Generic version of remdesivir at Rs 4,000 per vial launched by CIPLA
Cipla, Pharma Giant on Wednesday has announced that it has launched its generic version of antiviral drug remdesivir at Rs 4,000 per vial, which is among the lowest globally, and…
Nanotech Filter for making AC Safe from COVID
New Delhi: Nirvana Being, a leading Clean Air solutions company based on science and sustainability, has recently launched an all-in-one Nanotech AC Filter– a potential gamechanger in the nation’s quest for health and safety…

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices
Diabetic drug metformin found to act on brain
Hetero debuts semaglutide generic in emerging markets
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
Stem cell therapy for autism illegal: NMC advisory
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha